The Effect of Virtual Reality Application Diagnosed With Myocardial Infarction

NCT07696390 | Recruiting

• 1 other identifier: Myocardial Infarction - VR
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

This study was designed to investigate the effects of VR (virtual reality) glasses on vital signs and anxiety in conscious patients diagnosed with myocardial infarction and admitted to the cardiology intensive care unit.

Conditions

Myocardial Infarction

Keywords

Myocardial infarction, virtual reality, vital signs, stress

Outcome Measures

Primary Outcomes (4)

• Anxiety Level

  The patient's anxiety level will be measured using the State Anxiety Scale (STAI Form TX-1).

  Periprocedural

• Vital Signs - Blood pressure measurements (SBP, DBP)

  Blood pressure measurements (SBP, DBP)

  Periprocedural

• Vital Signs- heart rate

  heart rate will be taken.

  Periprocedural

• Vital Signs - respiratory rate per minute

  respiratory rate per minute will be taken.

  Periprocedural

Study Arms (2)

EXPERIMENTAL GROUP

EXPERIMENTAL

Participants will be shown a video with nature images through virtual reality glasses, and their vital signs and anxiety levels will be measured.

Other: virtual reality glasses

CONTROL GROUP

NO INTERVENTION

In this group, vital signs and anxiety levels will be measured as pre-test and post-test without any intervention.

Interventions

virtual reality glasses OTHER

Participants will be shown a video with nature images through virtual reality glasses, and their vital signs and anxiety levels will be measured.

EXPERIMENTAL GROUP

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• The patient is in intensive care.
• The patient has been diagnosed with myocardial infarction.
• The patient is between 18 and 70 years old.
• The patient is conscious.
• The patient is oriented and cooperative.
• The patient volunteers to participate in the study.
• The patient is open to communication.
• The patient agrees to participate in the study.
• The patient has no mental, visual, auditory, or speech impairment.
• The patient has undergone stent placement.
• The patient has STEMI.

You may not qualify if:

• The patient has a psychiatric disorder.
• The patient has any communication impairment.

Sponsors & Collaborators

• Yuzuncu Yil University: lead

Study Sites (1)

SBU Van Training and Research Hospital

Van, 65, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Vascular Diseases; Infarction; Ischemia; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Necrosis

Study Officials

• Yavuz Uren, Asst.Prof

  Van Yuzuncu Yil Universty

  STUDY CHAIR

Central Study Contacts

Yavuz Uren, Asst.Prof.

CONTACT

+905065961050; yavuzuren@yyu.edu.tr

Ayşe Özturk, MSc student

CONTACT

+905395934634; yavuzuren@yyu.edu.tr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Masking Details: Outcomes Assessor does not know whether patients are in the experimental group or the control group.
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal İnvestigatorI(Dr.)

Study Record Dates

• First Submitted: June 24, 2026
• First Posted: July 10, 2026
• Study Start: July 10, 2026
• Primary Completion (Estimated): September 18, 2026
• Study Completion (Estimated): September 18, 2026
• Last Updated: July 13, 2026

Record last verified: 2026-07

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)